Bioventus (BVS) Accumulated Expenses (2020 - 2026)
Bioventus' (BVS) quarterly Accumulated Expenses came in at $101.1 million in Q1 2026, down 2.08% YoY from $103.3 million in Q1 2025, and down 22.35% on a QoQ basis from $130.2 million in Q4 2025.
Bioventus (BVS) Accumulated Expenses (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Accumulated Expenses data on file, last reported at $101.1 million in Q1 2026.
- Quarterly Accumulated Expenses fell 2.08% year-over-year to $101.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $101.1 million (down 2.08% YoY) and the FY2025 annual result came in at $130.2 million, down 4.15% from the prior year.
- Accumulated Expenses slipped to $101.1 million in Q1 2026, from $130.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $146.8 million in Q3 2022 to a low of $101.1 million in Q1 2026.
- A 5-year average of $121.3 million and a median of $119.4 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses soared 39.44% — and 2025, when it retreated 18.8%.
- Tracing BVS's Accumulated Expenses over 5 years: stood at $111.6 million in 2022, then advanced by 7.37% to $119.8 million in 2023, then gained by 13.43% to $135.9 million in 2024, then declined by 4.15% to $130.2 million in 2025, then slipped by 22.35% to $101.1 million in 2026.
- The last three Accumulated Expenses figures came in at $101.1 million (Q1 2026), $130.2 million (Q4 2025), and $119.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 109.36 Mn |
| Mar 28, 2026 | 101.14 Mn |
| Dec 31, 2025 | 130.24 Mn |
| Sep 27, 2025 | 119.45 Mn |
| Jun 28, 2025 | 113.67 Mn |
| Mar 29, 2025 | 103.28 Mn |
| Dec 31, 2024 | 135.88 Mn |
| Sep 28, 2024 | 128.70 Mn |
| Jun 29, 2024 | 139.98 Mn |
| Mar 30, 2024 | 113.61 Mn |
| Dec 31, 2023 | 119.80 Mn |
| Sep 30, 2023 | 118.90 Mn |
| Jul 1, 2023 | 121.75 Mn |
| Apr 1, 2023 | 115.77 Mn |
| Dec 31, 2022 | 111.57 Mn |
| Oct 1, 2022 | 116.89 Mn |
| Jul 2, 2022 | 146.76 Mn |
| Apr 2, 2022 | 124.80 Mn |
| Dec 31, 2021 | 131.47 Mn |
| Oct 2, 2021 | 107.55 Mn |